Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS

v3.21.2
EQUITY TRANSACTIONS
9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
EQUITY TRANSACTIONS

NOTE 14 – EQUITY TRANSACTIONS

 

2021 Common Stock Transactions

 

During the nine months ended September 30, 2021, no new equity transactions have occurred.

 

 

2020 Common Stock Transactions

 

During the nine months ended September 30, 2020, the Company issued 1,132,500 shares of $.001 par value common stock to short-term note holders as required under their respective short-term notes valued at approximately $125,400.

 

During the nine months ended September 30, 2020, the Company issued 575,000 shares of $.001 par value common stock to short-term note holders as required under origination agreements for the respective short-term notes, valued at approximately $60,500 in aggregate, and this debt discount is amortized over the life of the agreements as interest expense.

 

During the nine months ended September 30, 2020, the Company issued 200,000 shares of $.001 par value common stock to short-term note holders as required under an extension agreement for the respective short-term note, valued at approximately $20,000.

 

During the nine months ended September 30, 2020, the Company issued options to purchase 60,000 shares of $0.001 par value common stock to a short-term note holder of the Company, at $0.10 per share. The options were in connection with a new short-term note, and therefore recorded as debt discount. The Company valued the options using the Black-Sholes model, using a volatility of 134%, a risk-free rate of 0.29%, and an expected term, using the simplified method, of 3.0 years. The fair value at grant date of $3,500 will be amortized over the vesting period and recorded as interest expense.

 

During the nine months ended September 30, 2020, the Company issued options to purchase 30,000 shares of $0.001 par value common stock to a short-term note holder of the Company, at $0.10 per share. The options were in connection with a new short-term note, and therefore recorded as debt discount. The Company valued the options using the Black-Sholes model, using a volatility of 134%, a risk-free rate of 0.30%, and an expected term, using the simplified method, of 3.0 years. The fair value at grant date of $2,000 will be amortized over the vesting period and recorded as interest expense.

 

Non-controlling Interest

 

The non-controlling interest presented in our condensed consolidated financial statements reflects a 46% non-controlling equity interest in PWS and 49% non-controlling equity interest in PelleChar. Net losses attributable to non-controlling interest, as reported on our condensed consolidated statements of operations, represents the net loss of each entity attributable to the non-controlling equity interest. The non-controlling interest is reflected within stockholders’ equity on the condensed consolidated balance sheet.